“…Concretely, this ToM Battery has been administered to TD preschoolers [25,26] and children at school age (6-15 years, [24]; 7-14 years, [27]; 6-7 years, [28]; 7-12 years, [29]). Concerning its' applicability, it has been administered to children presenting ASD [13,21,24,[30][31][32][33][34][35][36][37][38], ADHD [33], externalized behavior disorders [39], ID [40,41], developmental language disorders [23], deaf children with spoken language multilingualism [42] and to patients with brain injury [22].…”